DK0617620T3 - Anvendelse af 5-HT4-modulatorer til fremstilling af et lægemiddel til behandling af blærelidelser - Google Patents
Anvendelse af 5-HT4-modulatorer til fremstilling af et lægemiddel til behandling af blærelidelserInfo
- Publication number
- DK0617620T3 DK0617620T3 DK93900327T DK93900327T DK0617620T3 DK 0617620 T3 DK0617620 T3 DK 0617620T3 DK 93900327 T DK93900327 T DK 93900327T DK 93900327 T DK93900327 T DK 93900327T DK 0617620 T3 DK0617620 T3 DK 0617620T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- modulators
- medicament
- manufacture
- bladder
- Prior art date
Links
- 208000029162 bladder disease Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 210000003932 urinary bladder Anatomy 0.000 abstract 3
- 108091005482 5-HT4 receptors Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 2
- 206010011953 Decreased activity Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000009610 hypersensitivity Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Percussion Or Vibration Massage (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919127185A GB9127185D0 (en) | 1991-12-21 | 1991-12-21 | Pharmaceuticals |
| GB919127184A GB9127184D0 (en) | 1991-12-21 | 1991-12-21 | Pharmaceuticals |
| GB929219354A GB9219354D0 (en) | 1992-09-12 | 1992-09-12 | Pharmaceuticals |
| PCT/GB1992/002376 WO1993012785A1 (en) | 1991-12-21 | 1992-12-21 | Use of 5-ht4 modulators for the manufacture of a medicament for the treatment of the bladder diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0617620T3 true DK0617620T3 (da) | 1999-06-07 |
Family
ID=27265978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93900327T DK0617620T3 (da) | 1991-12-21 | 1992-12-21 | Anvendelse af 5-HT4-modulatorer til fremstilling af et lægemiddel til behandling af blærelidelser |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0617620B1 (da) |
| JP (1) | JPH07502528A (da) |
| AT (1) | ATE170747T1 (da) |
| AU (1) | AU671430B2 (da) |
| CA (1) | CA2126354C (da) |
| DE (1) | DE69226961T2 (da) |
| DK (1) | DK0617620T3 (da) |
| ES (1) | ES2121984T3 (da) |
| WO (1) | WO1993012785A1 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5852014A (en) * | 1992-03-12 | 1998-12-22 | Smithkline Beecham P.L.C. | Condensed indole derivatives as 5HT4 -receptor antagonists |
| US5998409A (en) * | 1992-03-12 | 1999-12-07 | Smithkline Beecham Plc | Condensed indole derivatives as 5HT4 -receptor antagonists |
| US5726187A (en) * | 1992-10-16 | 1998-03-10 | Smithkline Beecham Plc | N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists |
| TW344661B (en) * | 1993-11-24 | 1998-11-11 | Lilly Co Eli | Pharmaceutical composition for treatment of incontinence |
| EP0829474B1 (en) * | 1995-05-31 | 2003-04-09 | Nisshin Seifun Group Inc. | Indazole derivatives having monocyclic amino group |
| TR200103054T2 (tr) | 1998-06-15 | 2002-06-21 | Sepracor Inc. | Apne,bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (+)-norsisapridin kullanımı |
| EP1087765B1 (en) * | 1998-06-15 | 2005-03-30 | Sepracor Inc. | Use of optically pure (-) norcisapride in the treatment of irritable bowel syndrome |
| US6362202B1 (en) | 1999-03-02 | 2002-03-26 | Sepracor Inc. | Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
| US6353005B1 (en) | 1999-03-02 | 2002-03-05 | Sepracor, Inc. | Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist |
| TWI263496B (en) * | 1999-12-10 | 2006-10-11 | Novartis Ag | Pharmaceutical combinations and their use in treating gastrointestinal disorders |
| US20050261344A1 (en) * | 2002-08-14 | 2005-11-24 | Jones Charles R | Treatment of lower urinary tract symptoms associated with overactive bladder in men and women |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2044854A1 (en) * | 1990-07-19 | 1992-01-20 | Hong-I Chen | Method for preventing or treating urinary incontinence |
| GB9103862D0 (en) * | 1991-02-25 | 1991-04-10 | Glaxo Group Ltd | Chemical compounds |
-
1992
- 1992-12-21 DK DK93900327T patent/DK0617620T3/da active
- 1992-12-21 CA CA002126354A patent/CA2126354C/en not_active Expired - Fee Related
- 1992-12-21 WO PCT/GB1992/002376 patent/WO1993012785A1/en not_active Ceased
- 1992-12-21 ES ES93900327T patent/ES2121984T3/es not_active Expired - Lifetime
- 1992-12-21 DE DE69226961T patent/DE69226961T2/de not_active Expired - Fee Related
- 1992-12-21 AT AT93900327T patent/ATE170747T1/de not_active IP Right Cessation
- 1992-12-21 AU AU31683/93A patent/AU671430B2/en not_active Ceased
- 1992-12-21 EP EP93900327A patent/EP0617620B1/en not_active Expired - Lifetime
- 1992-12-21 JP JP5511526A patent/JPH07502528A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE69226961T2 (de) | 1999-04-29 |
| EP0617620B1 (en) | 1998-09-09 |
| EP0617620A1 (en) | 1994-10-05 |
| WO1993012785A1 (en) | 1993-07-08 |
| DE69226961D1 (de) | 1998-10-15 |
| AU671430B2 (en) | 1996-08-29 |
| JPH07502528A (ja) | 1995-03-16 |
| AU3168393A (en) | 1993-07-28 |
| CA2126354C (en) | 2006-07-11 |
| CA2126354A1 (en) | 1993-07-08 |
| ATE170747T1 (de) | 1998-09-15 |
| ES2121984T3 (es) | 1998-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0617620T3 (da) | Anvendelse af 5-HT4-modulatorer til fremstilling af et lægemiddel til behandling af blærelidelser | |
| BR9206237A (pt) | Uso de derivados de tetrahidrocarbazole como receptores agonistas 5-HT1. | |
| MX9700030A (es) | Administracion de pirenzipina, matilescopolamina y otros antagonistas del receptor mascurinico para el tratamiento de transtornos del metabolismo de lipidos. | |
| EA199800340A1 (ru) | Производные пиримидина как антагонисты 5нт2с | |
| AP9801272A0 (en) | Use of an antagonist of ppar-alpha and ppr-gamma for the treatment of syndrom X. | |
| BRPI0007823A8 (pt) | Métodos de supressão do glucagon | |
| DK0783893T3 (da) | Inhibering af unormal vækst af synovial-celler under anvendelse af il-6-antagonist som aktiv bestanddel | |
| MX9504687A (es) | Silla con patas ajustables. | |
| TR28275A (tr) | Kullanim sirasinda ayrilma yetenegine sahip bilesenler ihtiva eden adet bezi. | |
| EA200200503A1 (ru) | Способ лечения ревматоидного артрита | |
| FR2773160B1 (fr) | Resine de copolymere, sa preparation et photoresist utilisant celle-ci | |
| PT1319007E (pt) | Compostos de succinimida heterociclicos fundidos e seus analogos enquanto moduladores da funcao dos receptores hormonais nucleares | |
| CL2003002785A1 (es) | Uso de 4,5,6,7-tetrahidroisoxazolo(5,4-c)piridin-3-ol (thip) para preparar una composicion farmaceutica util para tratar un trastorno del sueno. | |
| MX9204786A (es) | Antagonistas del receptor 5-ht4 y composicion farmaceutica que los contiene. | |
| DK1098649T3 (da) | Fremgangsmåde til stabilisering af farmaceutiske sammensætninger med speciel anvendelse af antioxidant | |
| BR0317522A (pt) | Sistema para processar automaticamente componentes em um dispositivo | |
| ES2186783T3 (es) | Derivados de la dolastatina, su preparacion y uso. | |
| BR0111869A (pt) | Compostos cìclicos fundidos como moduladores da função do receptor para homÈnio nuclear | |
| DK0769293T3 (da) | Anvendelse af mindst en beta-adrenerg agonist som substans P-antagonist | |
| ES2171196T3 (es) | Uso de antagonistas del receptor cck-b para el tratamiento de trastornos del sueño. | |
| DK0696194T3 (da) | Anvendelse af indolderivater som 5HT1-antagonister | |
| LU88442A1 (fr) | Association synergisante ayant un effet antagoniste des récepteurs NK1 et NK2 | |
| EA199900450A1 (ru) | Агент, индуцирующий апоптоз | |
| EA200200303A1 (ru) | Синергетические комбинации антагониста рецептора nk1 и структурного аналога гамк | |
| DK1000046T3 (da) | Piperazinderivater, der er aktive på den nedre urinvejskanal |